Qi Ma

1.6k total citations
96 papers, 1.0k citations indexed

About

Qi Ma is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Qi Ma has authored 96 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 26 papers in Surgery and 20 papers in Molecular Biology. Recurrent topics in Qi Ma's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Liver physiology and pathology (9 papers). Qi Ma is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Liver physiology and pathology (9 papers). Qi Ma collaborates with scholars based in China, United States and United Kingdom. Qi Ma's co-authors include Junfeng Chen, Ming‐Hai Wang, Sunny Guin, Yue Cheng, Zejun Yan, Yong-Qing Zhou, Kejie Wang, Junhui Jiang, Rui Yu and Kaiyun Wang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Qi Ma

82 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Ma China 20 415 229 204 184 152 96 1.0k
Lin Sun China 19 403 1.0× 121 0.5× 175 0.9× 128 0.7× 218 1.4× 43 925
Yufeng Huang United States 22 667 1.6× 203 0.9× 188 0.9× 280 1.5× 79 0.5× 57 2.0k
Xi Liu China 20 573 1.4× 416 1.8× 416 2.0× 165 0.9× 258 1.7× 63 1.4k
Yan Yao China 21 793 1.9× 174 0.8× 411 2.0× 129 0.7× 257 1.7× 77 1.6k
Wenjie Chen China 21 482 1.2× 195 0.9× 285 1.4× 162 0.9× 212 1.4× 79 1.3k
Liang Zhu China 18 350 0.8× 136 0.6× 246 1.2× 225 1.2× 239 1.6× 52 942
Hongwei Lü China 23 814 2.0× 167 0.7× 311 1.5× 215 1.2× 191 1.3× 106 1.7k
Junfeng Hao China 18 365 0.9× 140 0.6× 187 0.9× 201 1.1× 156 1.0× 60 902

Countries citing papers authored by Qi Ma

Since Specialization
Citations

This map shows the geographic impact of Qi Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Ma more than expected).

Fields of papers citing papers by Qi Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Ma. The network helps show where Qi Ma may publish in the future.

Co-authorship network of co-authors of Qi Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Ma. A scholar is included among the top collaborators of Qi Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Ma. Qi Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhan, Shenghua, Yu Shen, Lili Huang, et al.. (2025). B7-H3 and CD39 Co-Localization in Gastric Cancer: A Potential Prognostic Biomarker and Potential Dual-Target for Immunotherapy. Technology in Cancer Research & Treatment. 24. 2244122845–2244122845.
2.
3.
Wang, Ming‐Hai, Qi Ma, Constantinos M. Mikelis, et al.. (2025). Humanized dual-targeting antibody–drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneity. Acta Pharmacologica Sinica. 46(5). 1375–1389. 3 indexed citations
4.
Xu, Yipeng, et al.. (2025). Mefloquine Suppresses Metastasis in Renal Cell Carcinoma Through Targeting SPC25. Cancer Science. 116(5). 1239–1254.
5.
Ying, Yang, Xinyan Li, Hua Zhang, et al.. (2025). Targeting the ATM-TRMT10A-BRCA1 axis confers synthetic lethality to PARP inhibition in metastatic castration-resistant prostate cancer. Science Advances. 11(41). eadw7989–eadw7989.
6.
Chen, Tong, Xudong Li, Lichen Yin, et al.. (2025). Targeting B7-H3 in Cancer-Associated Fibroblasts Using Nanosystems Suppresses Anaplastic Thyroid Carcinoma Progression. Thyroid. 35(10). 1173–1186.
7.
Hu, Pengcheng, et al.. (2025). WWP1 mediates the ubiquitination and degradation of HIPK3 in bladder cancer cells. Journal of Biological Chemistry. 301(6). 108528–108528.
8.
Wang, Kejie, Xiaolong Jia, Kaiyun Wang, et al.. (2024). RON receptor tyrosine kinase as a critical determinant in promoting tumorigenic behaviors of bladder cancer cells through regulating MMP12 and HIF-2α pathways. Cell Death and Disease. 15(11). 844–844. 2 indexed citations
9.
Xin, Fei, et al.. (2024). Promising therapy for neuroendocrine prostate cancer: current status and future directions. Therapeutic Advances in Medical Oncology. 16. 12714412–12714412. 6 indexed citations
10.
11.
Xin, Fei, et al.. (2024). Treatment of metastatic hormone-sensitive prostate cancer: from doublet therapy to triplet therapy. Postgraduate Medical Journal. 100(1188). 703–708.
12.
13.
Zhang, Jinfang, et al.. (2023). Value of detected hydronephrosis and hydroureter on ultrasound for detecting a ureteral stone: a retrospective study. Urolithiasis. 51(1). 67–67. 1 indexed citations
14.
Ng, Derry Minyao, et al.. (2021). Medical evaluation and pharmacotherapeutical strategies in management of urolithiasis. Therapeutic Advances in Urology. 13. 2080214868–2080214868. 3 indexed citations
15.
Jia, Xiaolong, Zejun Yan, Qi Ma, et al.. (2021). From “feeling” to “seeing”: modification of the percutaneous peritoneal dialysis catheter insertion with an optical puncture system. International Urology and Nephrology. 53(6). 1239–1245.
16.
Ma, Qi, Yang Chen, Jie Li, et al.. (2019). The Value of Shadowing and the Twinkling Artifact in the Diagnosis of Ureteral Stones: A Single-center Study. Urology. 126. 39–44. 5 indexed citations
17.
Chen, Junfeng, et al.. (2016). Anti-tumor effects of Atractylenolide I on bladder cancer cells. Journal of Experimental & Clinical Cancer Research. 35(1). 40–40. 85 indexed citations
18.
Wang, Ping, Dan Xia, Qi Ma, & Shuo Wang. (2014). Retroperitoneal Laparoscopic Management of Ureteropelvic Junction Obstruction in Patients With Horseshoe Kidney. Urology. 84(6). 1351–1354. 13 indexed citations
19.
Lu, Jie, M. Zhang, Yu Cao, et al.. (2011). Three-dimensional whole-brain perfused blood volume imaging with multimodal CT for evaluation of acute ischaemic stroke. Clinical Radiology. 66(6). 517–525. 5 indexed citations
20.
Ma, Qi. (2005). Model based control and efficient calibration for crank-to-run transition in SI engines. OhioLink ETD Center (Ohio Library and Information Network). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Sun Breakdown of academic impact, for papers by Yufeng Huang Breakdown of academic impact, for papers by Xi Liu Breakdown of academic impact, for papers by Yan Yao Breakdown of academic impact, for papers by Wenjie Chen Breakdown of academic impact, for papers by Liang Zhu Breakdown of academic impact, for papers by Hongwei Lü Breakdown of academic impact, for papers by Junfeng Hao
Rankless by CCL
2026